Cancer is a disease which occurs at the level of the genes. Personalized Cancer Gene Analysis is a more precise tool which helps develop successful therapies for our patients. Treating a cancer without cancer gene analysis can lead to inadequate therapy, which could allow the cancer to grow more aggressive over time. Also, trying to eliminate the cancer often annihilates the patient in the process, whereas using effective therapies allows us to contain the cancer, allows the patient to live longer, and enjoy a better quality of life, in spite of the cancer. With regards to cancer care, it often pays to use a new approach.
Our office is now offering Personalized Cancer Gene Analysis for patients who have had cancer, are currently battling cancer, have a family history of cancer, or have increased risk of developing the disease. From a simple blood sample drawn in our office, it is now possible to isolate, quantify, and genetically fingerprint migrating tumor cells. Cancer cells can migrate in the blood as soon as the tumor reaches 0.2 to 2 mm diameter, when it develops its own blood supply. These migrating cancer cells, or micrometastatic cells, may reach other organs where they can create new tumors. Therefore, we should test and isolate a patient's migrating cancer cells as soon as possible, quantify and genetically fingerprint them, and pharmacogenetically test the cells for the effectiveness of various medical therapies.
Each individual's cancer cells are evaluated for sensitivity to all 48 conventional chemotherapeutic agents and over 40 natural therapies. Based on the individual's test results, we can customize an individualized combination of chemotherapeutic agents, which will block the activity of multiple cancer genes. It is important to block the activity of multiple genes at the same time to successfully control cancer, because single therapies often allow the cancer genome to adapt and become more aggressive.
For those considering local or all-body hyperthermia, we recommend testing the expression of the genes that help the cells restore the damage induced by heat. There are several such genes that produce specific proteins, known as Heat Shock Proteins (HSP). When these genes are expressed normally in the cancer cells, they produce HSP, thus restoring any damage that hyperthermia may have caused. If those genes are down regulated, the cancer cells cannot restore after hyperthermia treatment. We can test the expression rate and quality of specific HSP genes that are proven to be related to Heat Shock Restoration and Hyperthermia Sensitivity. This gives us the ability to personalize the hyperthermia treatment to an individual's needs and to avoid severe side effects and/or potentially ineffective treatments.
Cancer is a disease which occurs at the level of the genes. Personalized Cancer Gene Analysis is a more precise tool to develop successful treatments for our patients. It is my recommendation that anyone who has a family history of cancer, has had cancer, or is currently battling cancer, seriously consider this blood test using cancer gene analysis for predicting drug sensitivity.
It takes only two weeks to get the test results, which show the tumor sensitivity to all conventional chemotherapeutic agents and to over forty natural therapies. The results demonstrate which chemotherapy or combination of drugs and natural therapies will have the best chance of stopping your cancer. Employing a personalized therapeutic approach prevents the use of ineffective and detrimental therapies, which could waste your time, hopes, and money.
If you are interested in this innovative approach, please make an appointment at your earliest convenience. Please call the Loma Linda office at 909-478-1100 or the North Tustin office at 949-726-0707.
Please feel free to share this information to anyone who may benefit from it.